Key result
Remote single-channel ECG monitoring detects prolonged QTc in ~8% of oncology patients undergoing polychemotherapy.
Why the study?
The incidence of prolonged corrected QT interval during polychemotherapy in primary oncological patients was not well characterized using remote monitoring.
Does remote single-channel ECG monitoring detect prolonged QTc intervals in primary oncological patients with elective polychemotherapy?
Observational (n=49)
Does remote single-channel ECG monitoring detect prolonged QTc intervals in primary oncological patients with elective polychemotherapy?
Remote single-channel ECG monitoring is an effective method for detecting QTc prolongation in oncology patients receiving polychemotherapy.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for remote QTc monitoring in oncology; prospective trials needed before clinical adoption.
Aim To evaluate the incidence of prolonged corrected QT interval (QTc) by remote single-channel electrocardiogram (ECG) monitoring in primary oncological patients with elective polychemotherapy (PCT).Material and methods This study included 49 oncological patients with elective PCT. A single-channel portable CardioQVARK electrocardiograph was used to record single-channel, one-lead ECG between the first and second courses of PCT.Results Analysis of QTc interval detected a prolonged QTc interval >500 msec in 8.2 % of cases, prolonged QTc >480 msec in 18.3 % f cases, and prolonged QTc interval >60 msec compared to baseline in 12.2 % of cases.Conclusion Remote recording of single-channel ECG using a portable electrocardiograph is an effective method for recording and detecting various forms of heart rhythm disorders.
No takes yet. Share an insight, caveat, or question.
Fashafsha et al. (2023) conducted an observational in Primary oncological patients with elective polychemotherapy (n=49). Remote single-channel ECG monitoring was evaluated on Prolonged corrected QT interval (QTc) >500 msec. Remote single-channel ECG monitoring detected a prolonged QTc interval >500 msec in 8.2% of oncological patients undergoing elective polychemotherapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: